SUBSCRIBE
Home Blog Page 5

Hedera (HBAR) Hits $0.1989 After Historic Nasdaq ETF Launch – Institutional Rally October 29 News

Sienna Wilson
-
0
Hedera (HBAR) Hits $0.1989 After Historic Nasdaq ETF Launch – Institutional Rally October 29 News

Hedera Hashgraph (HBAR) is soaring today, as it has soared by more than 17% to $0.1989 following the historic launch of the Canary HBAR ETF on Nasdaq.

As the third cryptocurrency to win a U.S.-listed spot ETF after Bitcoin and Ethereum, HBAR is bringing enterprise blockchain to Wall Street, and huge inflows of institutions are rushing into an unstable market. As the trading volumes shot 328% higher and the integration of stablecoins increases, the entire news of the explosive Hedera news of today is given.

HBAR Price Explodes to $ 0.1989 in ETF Breakout

HBAR was trading at a 10.75% premium, 0.1989 at the end of the day, when Bitcoin was down 1.68%. Immediate highs were at $0.2191, breaking through the 0.206 resistance level and then dropping more than above 0.197 on selling. The October corrections were offset by weekly gains, and at the end of November, the support is at $0.18,6 and the bulls are aiming at having the price at $0.266.

On-chain momentum cannot be denied: Whales accumulated significantly, RSI increased to 58 out of the oversold areas, and a symmetrical triangle breakout is an indicator of 45.5% growth to $0.305 quarterly highs.

According to analysts, annual highs of 0.4014 will happen should ETF inflows replicate BTC/ETH trends, which inflated 72 per cent in the months following approval. With the market in a fear-based downturn, the HBAR has resiliency that shouts the underestimation of enterprise-level utility.

Canary HBAR ETF Launches on Nasdaq: First Spot Altcoin Fund Launches

The bombshell: HBAR ETF (ticker: HBR) by Canary Capital was launched on October 28, and it keeps real HBAR in custody with BitGo and Coinbase. It was approved through the SEC generic standards in mid-September, during a U. S. government shutdown, bypassing the time-consuming reviews, making it an HBAR an institutional-grade asset.

This licensed car will allow RIAs, pensions and hedge funds to be spot exposed with no wallets – a Hedera Governing Council member game-changer of Google, IBM and Boeing. The trade began with Litecoin and Solana ETFs, and the volume of HBAR surged to $1.17 billion. Celebrating Hedera Foundation: In 19M+ cryptos on CoinMarketCap, Canary picked HBAR because of its scalability and compliance.

Stablecoin Boom: USDC Live on Bybit, Supply Increases 91.7%

USDC is now native on Bybit to Hedera users, alongside Binance, Crypto.com, and Gate.io (USDC supply increased 91.7% to $181 million; DEX volumes were at $64.4 million), and Q3 volume goes down 40% MoM.

Hedera remittances and payments kill competitors with its fixed fee of 0.0001 and 10,000TPS. On the one hand, the future of the CCTP V2 integration of Circle promises smooth bridging. Worldpay and UNDP enterprise pilots point to the practical rails with billions of tokenised assets.

Partnerships and Upgrades of Networks Celerate Uptake

The ecosystem is flourishing in Hedera: AI Studio is growing with decentralised agents, and NVIDIA integrations improve the performance 400,000x. PwC uses carbon tracking with Guardian, and Archax turns BlackRock/Aberdeen MMFs into pool tokens, making collateralised FX settlements such as those achieved by Lloyds.

At the time of dip (down 55% since highs of $396 million), DeFi TVL has dropped to $179 million, with SaucerSwap (64.6 million) and Stader dominating. Staking dropped to 28% of supply, compared with 42 back in June, but revenue and transactions recovered. The HBAR presents as a CBDC framework because of ISO 20022 compliance with the Central Bank of Nigeria through Emtech.

Technical Outlook: $0.5 in 2025, $1.70 by 2030?

Charts appear optimistic: Bullish: Break the resistance of 0.30, Wave 3 to hit 0.50 by the end of the year. On 5% CAGR, Elliott patterns put the eye at $0.95 lows to 1.70 highs in 2030. The ratio signalling of TVL/price value represents extreme underpricing with an influx of liquidity into ETFs.

Bear risks: Below $0.170 disintegration to $0.15 in case of increasing profit-taking. However, on-chain growth – 708,500 daily transactions (+ 25.8% QoQ) – is upside-leaning. Consensus: $0.222 max in 2025, $0.266in  November.

Why Hedera is 2025’s Institutional Powerhouse

The day that HBAR entered history, October 29, 2025: NASDAQ ETF, stablecoin boom, and enterprise upgrades drive it out of retail mania. Low-carbon, low-FT, and operated by titans, Hedera is offering 10K+ TPS to RWAs, DeFi, and AI – no ghost chain here.

With the index of altcoin season reaching 28, the asymmetric gains of the HBAR are in the 10.4 billion of its FDV. The ETF does not end, but it is the spark of the fire. Bulls are loading – the enterprise revolution takes place now.

How Settlement Agreement Solicitors Can Resolve Costly Business Conflicts

Danielle
-
0
How Settlement Agreement Solicitors Can Resolve Costly Business Conflicts

Business beefs are likely to get messy within a short time, and nobody wants to witness that endless drama. That is when the settlement agreement solicitors come in, sorting through all the mess before it turns out to be a costly affair.

Rather than fighting in courts, they assist enterprises in identifying smarter, more efficient alternative solutions to disputes. Their job extends much further than paperwork when it comes to preserving reputations, saving time, and money.

Even the most difficult of conflicts can be resolved fairly and professionally with the help of the right guidance. The ability to decide when to hire a settlement agreement solicitor can be the difference between long-term stability and sudden failure in the fast-paced workplace of today.

Why Business Conflicts Hurt Growth

Corporate conflicts hardly remain small. Ignore them, and they turn into monsters, eating up your time, cash, and trust. Here is why ignoring collaboration with settlement agreement solicitors and leaving conflicts unresolved can be deadly to growth and future prosperity.

Lost Productivity

Conflicts in the workplace blur priorities, waste both employee time and energy. Rather than focusing on performance, companies are left to deal with arguments and conflict.

Damaged Reputation

The excreta of conflicts besmirch the credibility. Client trust may be compromised by bad publicity or employee dissatisfaction, and attracting new talent or partners will be harder.

Legal Costs

Let the squabbles pile up, and you’ll find yourself in court, burning cash you should be using to grow. The money to be used in expanding the business is wasted in unnecessary lawsuits that can be resolved beforehand.

Employee Turnover

Unresolved conflicts create poor working conditions. Staff feel undermined or pressured, leading to resignation, which causes employee turnover and hiring and training costs.

Steps Solicitors Take to Resolve Disputes

Case Assessment

Attorneys dig through all the details, paperwork, and situation to get to know a conflict. This helps them in plotting the legal advantages and disadvantages and the best approach to beat them.

Risk Analysis

They determine the potential legal, financial, and reputational risks. This allows employers to make intelligent choices and eliminate the costly errors that result in needless protracted conflicts.

Legal Guidance

The solicitors explain the law and the legal decisions in simple terms. Their simplicity makes employers act without fear and stay in compliance without any misunderstanding or unintentional breaking of the law.

Negotiation Strategy

By creating a tailored negotiation strategy, solicitors can create opportunities to find a middle ground. They have an incentive to reconcile employer interests and encourage constructive solutions that are equitable.

Mediation Support

Sometimes conflicts may need neutral facilitation, and here solicitors assist in mediation. They brief their clients, deliver facts in a way that they are compelling to hear, and maintain constructive discussions, which increases the chances of resolutions that are peaceful. Recent UK data highlights how the government’s family mediation scheme is helping thousands of families reach agreements without going to court.

Document Drafting

Don’t try to wing the agreements. Get a proper solicitor to draft, double-check, and polish every word. Such agreements should be as precise as possible. A contract that is well-written and in line with the law will protect the employer against future claims or disputes.

Court Representation

Where a dispute advances, solicitors represent employers in court. They make powerful arguments, champion the rights of the parties, and pursue rulings that mitigate the economic and reputational damage.

Risks of Avoiding Settlement

Higher Costs

Lasting disputes lead to accumulating legal charges, lost management time, and lost productivity. Such gigantic expenses can be a strain on companies and affect the profitability of the business overall.

Reputation Damage

Conflicts that remain unresolved will tend to go viral and damage the reputation of a business. Client, employee, and stakeholder confidence can be ruined in a very short period by bad publicity or gossip in the workplace.

Employee Morale

There is always a conflict at the workplace, which diminishes motivation and cooperation. This also disrupts productivity because the employees experience insecurity or lack of appreciation, and turnover levels within teams are high.

Legal Exposure

The inability to resolve leads to heightened claims, governmental oversight, or even legal actions. Such risks subject business to unforeseeable results and even catastrophic economic impacts.

When to Involve Solicitors

Contract Disputes

Whenever clauses are ambiguous or violated, solicitors intervene to clarify conditions, secure rights, and make settlements to ensure that a dispute does not escalate into a protracted court battle.

Employee Issues

Whether it is wrongful dismissal, discrimination in the workplace, solicitors can offer guidance on employment law, protect the interests of the employer, and treat the client fairly at the lowest possible legal and financial cost.

Business Exits

By merging, acquiring, or dissolving partnerships, solicitors facilitate negotiations, draft terms of settlement, and ensure business continuity with the confidence that every party will come out fighting less.

Payment Conflicts

Cash flow may be disrupted by nonpayment or late payment of invoices. Solicitors can pursue the right action to enforce contracts and recover payments much more efficiently, and also retain business relations where possible.

Conclusion

Settlement agreement solicitors bring sanity, justice, and resolution to disputes and help businesses to avoid unwarranted risks, expenses, and preserve professionalism and smoother interpersonal relations to carry on with the growth.

THIQAH Engages Global Leaders at Sharjah and World Investment Conferences

ABC Staff
-
0
THIQAH Engages Global Leaders at Sharjah and World Investment Conferences

The IsDB Group Business Forum – THIQAH took part in the 29th World Investment Conference (WIC) and 8th Sharjah Investment Forum (SIF), held on 22–23 October 2025. Organized by the World Association of Investment Promotion Agencies (WAIPA), the Sharjah FDI Office, and the UAE Ministry of Investment, the two events brought together global leaders, ministers, CEOs, and investment promotion agencies (IPAs) from over 100 countries. Themed “Transforming Our World: Investing for a Resilient and Sustainable Future,” the forums focused on advancing global collaboration, sustainable investments, and innovative economic growth strategies.

During the conference, THIQAH played a pivotal role in promoting investment facilitation and partnership-building across IsDB member countries. THIQAH staff held numerous meetings with IPAs and promotion agencies from member countries, exploring co-investment opportunities, strengthening collaborations, and positioning THIQAH as a global platform connecting international investors with strategic projects in IsDB economies. The delegation also participated in high-level panels, workshops, and networking sessions, sharing policy insights, investment trends, and best practices in sustainable development.

THIQAH’s presence included a dedicated exhibition booth, showcasing IsDB Group’s programs, investment facilitation initiatives, and opportunities for private sector engagement. Key outcomes included enhanced visibility of THIQAH as a leading enabler of sustainable investment, identification of new partnerships and investment leads, and strengthened collaboration with international and regional IPAs.

By actively engaging with stakeholders and driving dialogue on innovative investment models, IsDB Group Business Forum – THIQAH reaffirmed its commitment to promoting responsible, inclusive, and resilient investment across member countries, contributing to the global “Decade of Promoting Investment for Good” and laying the foundation for future engagement at events like the Private Sector Forum (PSF) 2026.

HSBC Stock Smashes 8-Year Peak at 912p After Asia Boom Fuels Record FTSE Close

Sienna Wilson
-
0
HSBC Stock Smashes 8-Year Peak at 912p After Asia Boom Fuels Record FTSE Close

LONDON, October 29, 2025 – HSBC Holdings plc, the crown jewel of the FTSE 100 in the global banking sector, fired off a market rampage yesterday, raising its full-year income expectations, rocketing shares to a maximum eight-year high and sending the benchmark index to new all-time highs. This giant revamp, in the face of rumours of trade tensions and central bank generosity, restates the position of HSBC as a pillar of the UK’s financial strength.

Income Outlook Positive Review Leads to 5% Share Jump

When HSBC unleashed a bombshell announcement of its projected net interest income 15 per cent rise to $42 billion in 2025, it upended the industry expectations of the bank and highlighted how it has managed to sail through the unstable interest rates and the increasing demand in Asia. The revenues of wealth management are now projected to grow 20% annually due to the inflow of affluent clients in Hong Kong and Singapore.

Designed to be announced just before this morning’s trading bell, the announcement sparked off a scalding 5.2% rise in the share of HSBC (LSE: HSBA), topping out at 912p – the highest level since 2017. Volume surged to 180 million units, more than the monthly average, as BlackRock money flowed to Vanguard, accumulated, and in search of low-rate hangover yields.

This is not a blip; this is vindication. HSBC has made the shift to high-margin operations in Asia, and the dividends are already showing as the company recorded profits of 18.5 billion in the third quarter, an 8% increase over the previous year. Traders are talking with confidence: HSBC is in the ear of the Fed, London said, as the global yield sways.

FTSE 100 Peaks at 9704 During Banking Boom

On October 28, the FTSE 100 peaked at 9,704 points, 0.52% up, and 18% up yearly, and the HSBC halo effect shook the markets with its exterior effect. The Standard Chartered and the Lloyds followed suit, rising 2.1 and 1.8% respectively, as the investor expectations of rate cuts by the Bank of England and the ECB built up.

Against this euphoria, we can compare the continental malaise: the DAX of Germany gained by 0.1% but was strangled by manufacturing blues, and the CAC 40 of Paris dropped by 0.3% on fiscal jeopardy. London’s alchemy? A combination of tough banks, deflation of the shop prices, and the US-China thaw means that commodity plays such as Glencore and BP will be buoyed.

Yet, caution lurks. According to CBI data, UK manufacturers were recording the steepest order contraction since 2020, which gave an indication of Brexit trauma and supply headaches. Nevertheless, the energy of HSBC that controls 7% of the FTSE weighting silences the clatter, carving a record nearer that welcomes more bulls.

Asia-Centric Strategy is Handsomely Paying

The transformation of HSBC under the CEO, Noel Quinn, glows. Asia has become the centre of 60 of revenues (as compared to 45 years ago) with digital banking apps onboarding 5 million users in a quarter. It is sweetened by the extension of buyback, which was announced together with the upgrade, which yields 6.2% and trades at an attractive 7x forward earnings.

It is strategic repositioning at its best, analysts are singing, as HSBC has an advantage in cross-border flows in the context of RMB internationalisation. Risks? Geopolitical outbursts in the South China Sea and US tariff sabres may dent it, but diversified buffers UK mortgages, Latin American corporates, etc, make the fortress stronger.

Market Tidal Waves: Wall Street to Threadneedle Street

The S&P 500 of Wall Street was reflecting the enthusiasm of the FTSE, as employment in the country started to recover, and trade optimism, with the sterling falling 0.4 per cent to $1.28, polishing exporters. The story in the City is enhanced by the retail clang of Next that came earlier in the week: UK plc is putting all cylinders into action.

To HSBC loyalists, the future looks bright. It is estimated to bring in a profit of $45 billion by 2026 with a return on the tangible equity of 12. It is the inflexion, proclaims one of the fund managers, since the index stock of the 25% YTD surges is outstripping the index of 18%.

Barclays Resounds the Charge in FTSE Frenzy

Barclays (LSE: BARC) was not left behind with the stealthy rise of 1.5%, boosted by a 30% increase in investment banking fees, which increased on M&A revival. Market value is pushing PS55bn, and the dividend yield of 2.1% attracts income investors. However, the shadow of HSBC is enormous as its international presence overshadows the national competitors.

Fed Budget Watch, Budget Vigilantes

With the day of October 29 dawning, the FTSE futures are steadily ticking, and the budget fronted by Rachel Reeves is looming like a thunderhead, with its tax tweaks, which can be used to shock lenders.

In the meantime, Fed rate speculations are the talk of the transatlantic. So far, the success of HSBC is the climax of the story: in the uncertain waves, such an enormous banking giant manoeuvres the right way.

GSK Shares Leap 4% as Pharma Giant Boosts Guidance on Vaccine Breakthrough

Sienna Wilson
-
0
GSK Shares Leap 4% as Pharma Giant Boosts Guidance on Vaccine Breakthrough

GlaxoSmithKline plc (GSK), the pharmaceutical giant of the FTSE 100, shocked investors today with the second boost in its Full-Year profit expectations for this quarter, fuelled by blockbuster vaccine sales and a pipeline of oncology therapies to be developed. The stocks shot up in pre-market trading and established GSK as a healthcare lighthouse in an upbeat UK market.

Guidance Upgrade Ignites 4% Rally in GSK Stock

The third-quarter update by GSK showed that its sales increased 7.2 per cent to PS7.8 billion, beating expectations, as Shingrix shingles vaccine sales were up 15 per cent and its RSV vaccine sales were strong. The company now projects growth of core operating profits of 6-7% in 2025, increasing to 5-6, and earnings per share will increase by 8%.

The announcement saw GSK shares (LSE: GSK) jump 4.1 per cent to 1,856p in the opening trades, the best in more than a year. The frequency of trading doubled the average, and Legal and General, to Schroders, hunched healthcare funds, swimming in the defensive nature of the sector when the market was rough.

The update comes right after the announcement of a change of leadership of the PS70 billion giant by CEO Emma Walmsley, who will soon be succeeded by Luke Miels, who promises to make the company profitable in the sphere of biologics. The market watchers expressed that the innovation engine of GSK is operating on all cylinders as the stock gains 12% in the course of the year to date.

FTSE 100 Returns on Streak Pharma Lift

The FTSE 100, which rose by 9,704 points the day before, lifted a little in the first trade, and GSK rose to offset miner grabs by the wobble in commodities. AstraZeneca and Haleon followed, up 1.2% and 0.8% as healthcare 15% of the index flexes its muscle over cyclical colleagues.

In Europe, the STOXX 600 index made a lethargic open, troubled by blues in the auto industry and Wall Street futures were cautious before Fed comments. The GSK wave resonates with the Next retail below, and the HSBC bank assault in the UK, and gives the impression of diversification prowess in London equities.

However, there are undertones: UK price pressures data tomorrow would tip BoE rate markets, and manufacturing concerns remain troubled according to CBI polls. Its stability is, however, a setback because the 3.8% dividend yield of GSK tempts traders of income.

Pipeline Fuel Pharma Renaissance Vaccine Sales

The rise of GSK can be traced back to strategic bets that work out. The vaccines Shingrix, which has become a PS3 billion annual earner, took 70% of the market share in the US, and the Arexvy RSV vaccine had first-year sales of PS1.2 billion. The Jemperli oncology hopefuls made progress in their trial, with Jemperli forecasting PS5 billion peak revenue by 2030.

In Q3, the R&D expenditure of the firm reached PS1.5 billion, with an objective of 20 new launches by 2028. Consumer health divestitures to Haleon have improved the focus to 28 per cent margins from 25 per cent last year. Asia-Pacific expansion of 12% underscores global presence, the insiders say, “Precision medicine is the north star of GSK.

GSK invites value investors at 12x forward earnings – a bargain in comparison to the sector averages. Board confidence is indicated by a PS2 billion share buyback, which has been extended today.

Tailwinds and Trials Ahead Investor Horizons

Looking ahead to the year 2026, GSK is aiming to achieve 7% sales growth, and this will be anchored on immunology and HIV franchises. Tailwinds: The ageing population and reforms on US drug pricing in favour of innovators, but older assets face patent cliffs.

Risks? Trade hurdles in Europe and China will hurt, but diversified revenues – 55% of vaccine – cushion hits. To holders, the current lift is a 15 per cent upside on analyst targets.

AstraZeneca Shadows GSK in Healthcare Hot Darling

Eventually, AstraZeneca (LSE: AZN), a fellow FTSE pharma titan, rose 1.5% back to its position at London’s biggest stock cap of PS180 billion, on speculation of improved cancer therapy news. However, the vaccine pace of GSK takes the centre stage, its 4% pop dominating the level-headed ascendancy of AZN.

UK Equities Eye Fed, Inflation Curve Balls

The situation on October 29 is stable with the FTSE futures, whereas trans-Atlantic Fed signs and domestic CPI overshadow big. As GSK prospers, the life sciences business in London shines, and bets have been taken on the limitless horizon of biotech.

Next Shares Surge as Retail Powerhouse Lifts Profit Guidance to Record £1.135 Billion

Sienna Wilson
-
0
Next Shares Surge as Retail Powerhouse Lifts Profit Guidance to Record £1.135 Billion

LONDON, October 29, 2025 – FTSE 100 heavyweight Next plc has again increased its annual profit outlook in a spectacular showing of consumer strength by increasing expectations to an outrageous PS1.135 billion in the year to January 2026.

It is the fourth consecutive increase in only eight months, which drove shares skyrocketing in the initial trading and highlighted the unsurpassed leadership of the retailer in the economic headwind.

Investor Frenzy Fueled by Quarterly Sales Beat

The third-quarter full-price sales of Next jumped 10.5% up until October 25 and broke the expectations of the analysts and surpassed the previous quarter. The domestic sales to the UK had increased by 5.4, and the overseas sales had increased by a staggering 38.8, which was driven by Next’s large e-commerce platform in over 70 countries.

The market leader with more than 800 bricks-and-mortar stores in the UK and Ireland (including such giants as Reiss, Joules, and Fatface) now projects a 7.0% full-price sales growth in the crucial fourth quarter. The change is contrary to the previous assumptions of a weakening in the second half to 4.5% which had considered a weakening UK economy.

The stock of Next (LSE: NXT) surged over 3 per cent in midday trade, continuing to reach a 52-week high of 13,555p that the company had recently achieved. The volume levelled off to the highest point, and institutional investors who were betting on a continuance of the momentum rushed in.

PS1 Billion Milestone to New Heights

Last year, Next crossed its PS1 billion pretax profit barrier with a PS1.011 billion performance. The current improvement of the previous PS1.105 billion is a significant leap, which actually justifies the aggressive growth approach employed by the CEO, Simon Wolfson. The company has skillfully overcome increased warm weather, a cyber attack by a competitor, and changes in consumer habits to online shopping.

Viewers of the market observed that Next has continued to perform well in a difficult retail environment. As the UK accounts for 80% of the sales, the performance of the group is a crucial pulse-check on how well British people spend their money. Shoppers are rushing into value-based collections and omnichannel experience at Next despite their cautions of economic uncertainty.

FTSE 100 Stable in the Wider Warning

The wider FTSE 100 surged close to the record levels, frustrated by the expectation of the rate move by the Federal Reserve of the US. Banking powerhouses such as HSBC and Barclays offered lift-off yesterday; however, today the attention is directly on Next in the midst of a reluctant European crowd destined to open with a more muted performance.

The success of Next is at odds with those struggling with the inflationary pressures and restraining discretionary spending. Competitors such as Marks and Spencer, who are yet to fully recover after the recent downages, are shown pale in comparison as Next continues to establish itself as the retail kingpin in the UK.

Strategic Mastery: Online Boom and Brand Purchases

The core of the Next Rise is its online expertise. More than half of the sales are now made through e-commerce and international platforms that offer the Next brand and 700 third-party brands. Such strategic acquisitions as Joules and Fatface have boosted expansion by incorporating a local and a global presence.

The analysts celebrate the inventory discipline and pricing savvy of the group, which has cushioned margins against the events of cost spikes. This is not luck, it is execution and one of the City experts pointed out. Attractive forward P/E ratios are at approximately 15x, where value hunters will find dividends and buybacks attractive.

What Does the Future Hold for Next Investors?

Next is looking at mid-single-digit sales growth to 2026, supported by store refreshes and additional incursion overseas. The possible tailwinds are stabilising interest rates and wage increases, but there is a threatening influence of geopolitical tensions and snarls in supply chains.

To the stockholders, the modernisation today is an indicator of the future. The 20% year-to-date increase in the stock is below that of the FTSE, which indicates that the stock can go up. “Buy the dip? None, traders quip, as Next reinvents the retail playbook.

Barclays Steals Spotlight in FTSE Hot Streaks

Although Next captures the headlines, another FTSE 100 heavyweight, Barclays (LSE: BARC) was quietly on a 50 per cent increase in 2025, crushing the 15 per cent rise of Tesla. Shares were up PS55.9 billion market cap, the highest since 2008, fuelled by roaring investment banking fees. It trades at 10x earnings with a yield of 2.1% which is the dream of a banker in a volatile world.

UK Markets Eye Global Cues

Eyes shift on Wall Street and Fed signals as London merchants devour the Next bounty. However, as the retail giants such as Next shine, the UK equity picture is brightening. Investors: dig out a parade.

How Managers Can Ease the Transition After Rehabilitation

Claire James
-
0
How Managers Can Ease the Transition After Rehabilitation

An employee’s return to work after completing a rehabilitation programme is a critical point in their recovery journey. They arrive with new skills and a commitment to their wellbeing, but they also face significant challenges. As a manager, your support can be the deciding factor in their successful workplace reintegration. A thoughtful and compassionate approach not only helps the individual but also strengthens your team and fosters a healthier, more supportive company culture.

This guide will explore how you can ease this transition. We will cover the realities of addiction recovery, the manager’s role in creating a supportive environment, and practical steps you can take to help your employee thrive upon their return.

Understanding the Rehab Journey

To provide effective support, it’s helpful to understand what an employee has been through. Programmes like cocaine rehab or broader residential rehab are intensive, structured environments designed to address the complex nature of addiction.

Treatment is not just about stopping substance use. It involves deep therapeutic work to uncover the root causes of addiction. During their time in residential rehab, an employee will have participated in individual counselling, group therapy, and educational workshops. They learn coping mechanisms, stress management techniques, and strategies for preventing relapse. An extended stay in cocaine rehab, for instance, helps individuals rewire thought patterns and behaviours developed over a long period.

Returning to daily life after this immersive experience is a significant adjustment. The employee is navigating a new way of living without the 24/7 support structure of the treatment centre. They may feel anxious, overwhelmed, or emotionally fragile. Understanding this context is the first step towards providing meaningful support.

The Manager’s Role in a Supportive Return

Your position as a manager is pivotal. You can create an environment that either supports or hinders an employee’s long-term recovery. The goal is to build a foundation of trust and open communication, empowering the employee to succeed in their role while prioritising their health.

Provide a Supportive Environment

Your attitude sets the tone for the rest of the team. Greet the returning employee with warmth and positivity, treating them as a valued member of the team. Focus on their professional contributions rather than their personal history. A welcoming atmosphere helps reduce feelings of shame or isolation, encouraging the employee to reintegrate with confidence.

Maintain Clear Communication

Before the employee returns, schedule a private meeting to discuss their transition. This is not a time to pry into the details of their treatment but to establish clear, professional boundaries and expectations.

Discuss their role, any changes that may have occurred in their absence, and what a realistic workload looks like. Frame the conversation around professional success. Ask questions like, “What support do you need from me to do your best work?” or “How can we structure your first few weeks back to ensure a smooth transition?” This collaborative approach shows you are invested in their success.

Practical Steps for a Smooth Transition

Clear intentions must be backed by concrete actions. The following steps can make a tangible difference in an employee’s return-to-work experience after rehab.

Offer Flexible Work Arrangements

The initial period after residential rehab is often packed with aftercare appointments, support group meetings, and therapy sessions. Where possible, offer flexibility. This could mean adjusted hours, a hybrid working model, or the ability to attend appointments during the workday. This accommodation demonstrates that you respect their commitment to ongoing recovery and trust them to manage their responsibilities.

Create a Safe Space for Dialogue

Let the employee know your door is open for work-related discussions and that conversations will be handled with confidentiality and without judgement. Stigma is a major barrier to addiction recovery. By fostering an environment of psychological safety, you make it easier for an employee to voice concerns about workload or stress before they become overwhelming. You are not their counsellor, but you can be a trusted and supportive manager.

Connect Employees to Workplace Resources

Ensure the employee is aware of all available workplace wellbeing resources. This includes Employee Assistance Programmes (EAPs), mental health first aiders, or any internal support networks. Remind them how to access these services confidentially. Making this information readily available normalises its use and reinforces the company’s commitment to employee health.

Promoting Ongoing Support for Lasting Recovery

Workplace reintegration is not a one-time event; it’s an ongoing process. Continued support is essential for sustainable recovery and professional growth.

Encourage Peer Support and Mentoring

If appropriate within your company culture, consider pairing the employee with a trusted colleague or mentor. This person can help them get back up to speed on projects and navigate social dynamics within the office. A friendly face can make a huge difference in helping someone feel reconnected and less isolated after a long absence.

Conduct Regular, Supportive Check-Ins

Schedule regular, informal check-ins during the first few months. Keep these meetings brief and focused on work, but also create space to ask, “How are you getting on?” Listen actively and observe their wellbeing. These check-ins allow you to proactively address any challenges with workload or stress and make adjustments as needed.

Encourage Participation in Aftercare Programmes

Aftercare is a vital component of recovery from any addiction, including that addressed in cocaine rehab. These programmes provide the ongoing support structure needed to maintain sobriety. While you should never mandate or track participation, you can foster a culture that supports it. By offering flexibility for appointments, you indirectly encourage employees to stay engaged with their aftercare support system.

Your Compassion Makes the Difference

Supporting an employee returning from rehab is one of the most impactful ways you can demonstrate compassionate leadership. Your empathy, understanding, and willingness to provide practical support can transform a challenging transition into a story of success. By championing your employee’s wellbeing, you not only help them reclaim their career but also build a more resilient, loyal, and humane workplace for everyone. Prioritise empathy and support—it is an investment that pays dividends in both people and performance.

Hyperliquid HYPE Hits $58 as Equity Perps Launch and TVL Soars to $2.4B

Sienna Wilson
-
0
Hyperliquid HYPE Hits $58 as Equity Perps Launch and TVL Soars to $2.4B

29 October 2025 – The native token of Hyperliquid, called HYPE, is being lit on fire today, as it continues to lift up to over 58% and heads towards its all-time high as the decentralised perpetuals giant conquers the world of derivatives trading.

Having total value locked (TVL) skyrocketing to $2.41 billion, and monthly volumes surpassing 58 billion, Hyperliquid is overtaking competitors and absorbing 40% of Layer-1 fees.

Whales are doubling, a giant $1 billion buyout plan is driving the speculation, and the new equity perpetuals are being offered, which is an indication of the invasion of TradFi. With Q4 heating, HYPE is establishing itself as the hottest DeFi play in crypto, where the forecast shows the price will reach at least $80 in November.

Equity Perpetuals Go Live: Hyperliquid Bridges Crypto and TradFi with 24/7 Stock Trading

The talk in crypto is Hype of Hyperliquid, which recently launched equity perpetuals, enabling the user to buy or sell tokenised forms of blue-chip stocks such as Apple, Tesla, and Nvidia on-chain. This is not another feature but a head-on confrontation of centralised brokers, which has zero-expiry contracts with leverage of up to 50x, all in USDC.

These perps are designed around Hyperliquid’s high-speed Layer-1 blockchain and charge no more than 0.02% but provide sub-second execution even faster than other sites like Robinhood.

The initial volumes already exceeded $500 million in the first 24 hours, attracting institutional investors worried about regulation on spot ETFs. It is touted by developers as a “TradFi killer” and allows a smooth composability of DeFi primitives to yield-bearing stock positions.

This will see Hyperliquid enter the $100 trillion equities market, expanding out of crypto perps, and making HYPE the entry point to cross-asset speculation. At a dollar funding rate of 0.01, the risk engine of the platform is bulletproof even on a day when the market went down by a small margin.

TVL and Volumes Skyrocket: Hyperliquid Takes 40% of L1 Fees, Overtaking Solana

The rise to DeFi royalty is indisputable to Hyperliquid. TVL has increased 150% in the year to date to $2.41 billion, which was driven by sticky liquidity pools and unlicensed market creation through HIP-3. Perpetual volumes have reached 58 billion in April last month, competing with Binance DEX arm and surpassing Solana, losing 9% down 50% this year.

On-chain indicators are also extremely positive, with 250,000 active users becoming the highest number to date, an increase of 300 per cent compared to Q3, and staking rewards that attract long-term holders with 15 per cent APY on HYPE.

This platform currently controls 60% of L1 fees with BNB Chain, which is a sharp switch to the alt-L1 domination in early 2025. This source of revenue, which is dependent on derivatives, is 1.2 billion annually and used to finance ecosystem grants, such as 100 million in AI-based trading bots.

The fluctuation in funding rates in booms is criticised, though proponents believe it is the cost of innovation. With Bitcoin stuck at $98,000, money is moving into high-beta investments such as Hyperliquid, and the 10.71% 30-day volatility of HYPE is indicating unexploited potential.

Whales Bet Big: $1B Buyout Plan Ignites 12% Rally, Top Traders Eye $80

The unspoken force behind the movement of HYPE is whale activity. On-chain sleuths identified HYP payments of $200 million to cold wallets over the weekendfronted by a pseudonymous fund averaging in at $52. Live trackers indicate the best P&L traders who are shorting ETH in Hyperliquid and longing HYPE, and a $14 million position on one whale is about to be liquidated only above 16,000 -miles off the ground.

The real fireworks? The bombshell news of HyperLiquid Strategies to raise $1 billion in a HYPE treasury buyback, which increased the token 12% to 47.63 on October 23. This accumulation of strategic forms promotes the best practices, such as UNI buybacks, in which they wish to burn 5% of the supply and increase scarcity.

Although a TD Sequential sell signal was flashing yesterday, giving indications of a pullback to 50, bullish divergence on RSI (rising between 45 and 65) indicates that buyers are in charge. This week, exchange outflows reached 5 million HYPE, according to Glassnode, which highlights the conviction in a larger market calm.

The Airdrop Legacy Rewards: 30% Supply Drop Leads to 19x Profits and Community Loyalty

The token generation event (TGE) at Hyperliquid is still a masterpiece in the field of community bootstrapping. The project was virally adopted by providing over 30% of the supply to initial users and traders, close to 10%, more than usual. Jumping to the present, HYPE has generated 19x returns since its inception, and such metrics as TVL and volumes are perpetually in the uptrend.

This airdrop model is known as net-positive by one analyst; this is a contrast to sybil-riddled drops elsewhere. It brought about true participation: According to internal dashboards, 70% of recipients are still actively trading, which leads to organic growth. It is now emulated by projects such as Dango, which reserve 50-60 per cent to users and attribute the loyalty to the high bar of Hyperliquid.

The HIP-3 permissionless perps receive 92% approval, and governance has the power to spawn markets on niche assets such as meme coins or RWAs. This decentralised attitude, combined with cross-chain bridges to Ethereum and Solana, keeps the flywheel of HYPE spinning.

Price Projections Thaw Off: $80 in the Short, $150 in 2026 Under Bearish Sentiment Reversion

HYPE projections are grossly optimistic. The latest model updated at CoinCodex, based on the 50-day SMA, sets it at $45 by November, although a switch of the sentiment of bearish (Fear & Greed at 30) to neutral will carry the model to 80. Long term: $150 in the middle of 2026 under the assumption that the volume of derivatives will grow twice as much as the volume of equity perps.

Technicals match: HYPE dropped down to $31.68 lows and up to $59.2 YTD highs, creating a cup-and-handle on the weekly chart. MACD bullish cross over and a percentage of 47% green days in 30 sessions scream momentum. However, a 10-15 per cent pullback is not out of the question with FOMC looming, a perfect dip-buyer of the 200-day SMA of $38.10.

HYPE has a market cap of $10 billion against the peers of its $252 billion per month volume, which is trading on a fraction of the multiples of Jupiter, despite having just as high perps dominance.

Development Frenzy and Partnerships: Unlock Bitget Wallet Integration with Mass Adoption

Last week, Hyperliquid saw 1,200 commits to HyperEVM upgrades to support the EVM and deBridge cross-chain swaps. Bitget Wallet, which has been live since yesterday, offers native mainnet access, in-built LiquidLaunch trading and a DApp zone to ecosystem projects, rewarding its users with points to gain smooth Hyperliquid access.

There are also plenty of partnerships: Collaborations with Chainlink to feed the oracle and BNB Chain to the liquidity route outreach. Projections of revenue? According to ecosystem roadmaps, $30 million in 2025, increasing to billions in 2030. It is not marketing, but implementation, and it is expected to have 25 million users by the end of the decade.

Avoiding Risks: Liquidation Wounds Heal as Platform Matures

The scars of October are still there: The mid-month sell-off, which arose due to the anti-tariff increases in the U.S., wiped 1,000+ wallets in Hyperliquid, leaving behind 1.23 billion dollars ‘ worth of the biggest event in its history. More than 6300 of the accounts went red, 205 million-dollar losers, highlighting the two-sided sword of perps.

However, the platform showed reverse strength, and the top 100 traders got a profit amounting to 1.69 billion. Further risks are reduced by improved risk management mechanisms such as dynamic leverage limits. When the rate of funds is close to zero, there is no excess of feeling, no overheated longs to wipe his eyes.

Hyperliquid’s Horizon: From Perps Pioneer to Multi-Asset Empire

Hyperliquid will cross its inflexion point in October 2025. Equity perps break silos, TVL and fees are on top of L1S, whales create buybacks, and airdrop alchemy gains unshakable loyalty. HYPE will trade like a steal at $58, yet, undervalued and unstoppable.

To the traders, the playbook is easy: Scale in when at dips, leverage when it is prudent and HODL when volatility strikes. Hyperliquid is not merely trading, but it is also reinventing it, with $60 ATH on the horizon, and a $100 trillion playground for the future. It is the derivatives revolution; the revolution that doesn’t want to leave anyone behind.

The Evolution of Supplement Dispensing: Providers Review Their Experience with Fullscript

ABC Staff
-
0
The Evolution of Supplement Dispensing: Providers Review Their Experience with Fullscript

In the last decade, the way healthcare providers dispense supplements has undergone a quiet revolution. Gone are the shelves of dusty inventory, the handwritten logs, the manual reordering processes. In their place, digital platforms like Fullscript have reimagined how providers recommend and deliver supplements—combining clinical precision with logistical simplicity.

A Problem Born of Practice

The idea behind Fullscript didn’t come from a boardroom. It came from the clinic floor.

In 2011, naturopathic doctor Alanna Dyment found herself overwhelmed—not by patients, but by product boxes. Managing supplement inventory, juggling invoices, and keeping up with stock was swallowing the time she wanted to spend on patient care. Her husband, Brad Dyment, saw the burden firsthand and joined forces with Kyle Braatz and Chris Wise to create a solution. What began as a tool to solve one provider’s logistical headache would evolve into a platform now used by over 100,000 providers across North America.

For many, that shift was long overdue.

Dr. Dan Kalish, a functional medicine provider who transitioned to Fullscript in 2018, puts it plainly in his Fullscript review: “After 25 years of stocking and selling supplements, I finally switched to Fullscript. What a difference! I cut my expenses and increased the range of top-quality supplements I can recommend. My office staff has way less work.”

A Platform That Grew with the Profession

Fullscript didn’t stay static. It scaled. And with each new chapter, it responded to the profession’s growing complexity.

The 2018 merger with Natural Partners opened the door to a broader catalog and added wholesale functionality. Four years later, the acquisition of Emerson Ecologics introduced deeper industry ties and fortified quality assurance programs—adding rigorous standards to a platform already known for provider trust.

Dr. Meghan Walker, who’s been using Fullscript since 2013, has watched that evolution from the inside. “I use Fullscript because I’m always looking for the most impactful tools to support my patients,” she says. “It drives compliance and ultimately health outcomes because it takes the hassle out of filling my prescriptions and gives purchasing control back to my patients.”

A Changing Set of Tools for a Changing Era

Providers who adopted Fullscript more recently are often drawn by features that didn’t exist in its earliest forms. For some, it’s the enhanced ability to monitor patient adherence. For others, it’s the seamless experience across devices and locations.

Dr. Ronald Hoffman, who joined the platform in 2018, values the flexibility it brings to clinical follow-up. “Since adopting Fullscript, I’ve expanded my capability to offer a far greater range of innovative supplements,” he explains. “It enables me to better track patient compliance and make midcourse corrections with personalized instructions—at the stroke of a key, 24/7, from wherever I happen to be.”

And for many providers, the real measure of a dispensing platform isn’t what it looks like on the back end—it’s how patients respond.

Dr. Chris Oswald sees the value clearly: “Fullscript lets patients receive prescriptions, communicate with me directly, and easily reorder. The convenience is huge. When they’re running out of something, there’s no need for an appointment.”

Elevating Trust Through Testing

At a time when the supplement market is flooded with questionable products and vague labeling, Fullscript has invested heavily in maintaining quality. Through its Quality Programs, the platform conducts product testing using independent labs. More than $10 million annually goes into vetting suppliers, auditing facilities, and ensuring that what providers recommend is safe, consistent, and effective.

That reliability isn’t just marketing speak. It’s foundational to the provider-patient relationship.

Dr. Rob Kachko, who began using the platform in 2019, puts it this way: “Working with Fullscript gives me a sense of comfort knowing that our patients can continue to have reliable access to the brands and products our clinic knows and trusts.”

A Model for What Comes Next

From its roots as a workaround for a single clinic to its current role in shaping how whole person care is delivered, Fullscript reviews reflect how thoughtful technology can support—not replace—the clinical relationship.

It didn’t digitize supplement dispensing just for the sake of convenience. It reengineered it around what providers actually need: evidence-based product access, trusted supply chains, workflow efficiency, and patient empowerment.

If the early years of digital health were focused on recordkeeping and remote visits, the next phase may be defined by platforms like Fullscript, ones that quietly optimize the in-between moments of care, where follow-through often determines outcomes.

And in the words of its earliest users, the best part might be what it gives back: time, trust, and room to focus on the work that matters.

Cardano Hits $0.65 as Alonzo EVM Goes Live and ETF News Heats Up

Sienna Wilson
-
0
Cardano Hits $0.65 as Alonzo EVM Goes Live and ETF News Heats Up

October 29, 2025 -In a seismic change in the cryptocurrency market, the native token of the Cardano ADA is taking the stage today, with the successful launch of the hotly awaited Alonzo EVM upgrade. At about $0.65, ADA has recovered from the recent falls and is bouncing back due to its strength in the overall market fluctuation.

Whales are accumulating on the down-low, technical patterns are screaming breakout, and the rumours of ETF approvals are adding to the mania. Towards the end of October, Cardano is the most followed cryptocurrency of the month and is well placed to record tremendous returns in 2025.

Alonzo EVM Releases Ethereum Compatibility – A Breakthrough for Developers

The masterpiece of the current headlines is a smooth rollout of the Alonzo EVM upgrade on the Cardano mainnet. This critical update brings together the solid proof-of-stake design of Cardano and the Ethereum-dominated smart contract platform, which gives developers access to EVM-compatible dApps directly on the blockchain of ADA without the hassle of cross-chain interoperability.

Launching with thorough testing periods, Alonzo EVM will reduce deployment costs by as much as 90% over Ethereum gas fees, and share the same levels of scalability and security as Cardano. There are already early adopters and migrations announced: DeFi protocols, NFT marketplaces and gaming platforms are migrating their operations to Cardano and adding more liquidity to its ecosystem.

This upgrade is not simply technical genius – it is a strategic genius. With the ability to absorb the Ethereum $400 billion DeFi TVL, Cardano will be able to take a huge portion of the pie, effectively propelling the ADA demand into the heavens. The market analysts observe that a 300% has been seen in the post-upgrade transaction volumes in the past 24 hours, and adoption is urgent.

Whales Build Cryptically: Bullish Triangle Action Foreshadows 150% Rally

In the background, there is a group of deep-pocketed investors who are plotting the comeback of ADA. On-chain data shows that whales – addresses with more than 1 million ADA – purchased 250 million tokens in the last week alone, and on average at a price of 0.62. This buildup is not compliant with the humble 2% downward daily dip of the token, an indicator of a belief in the imminence of the reversal.

Trends are also in line: ADA is curling in a multi-month ascending triangle, and its resistance is at $0.70, and support is at $0.58. A strong breakout above $0.70 would trigger a parabolic surge with short-term targets of 0.85 and long-term targets of 1.70 by the end of the year. Positive expectations speak of 5 ADA in the 2025 bull run, with historical backgrounds supporting these trends with 150% plus returns.

One trader said that the fundamentals of Cardano have never been better. Exchange balances are approaching cycle lows, ETF inflows are strong, and sentiment indicators are green. With Bitcoin stabilising at a price of above 100,000, the altcoins such as ADA are set to be rotated.

Cardano Leaders with AI-based Payments Using the x402 Protocol

Cardano is taking on a bold step into the future and adopting the x402 standard of Coinbase, so that autonomous agents of AI-based agents can make payments on-chain without issues. This is a very big step, as developers refer to it, it enables the AI models to process micropayments to services such as data processing or content generation without human involvement.

x402 support is tested by the blockchain team at Masumi and would make Cardano an AI economy hub. Think about ADA AI-based tutors charging per lesson, or predictive analytics paying per real-time feed. This makes Cardano a leader in the trillion-dollar AI-blockchain convergence over its competitors.

Charles Hoskinon, one of the founders of the company, responded to the news with enthusiasm, noting that it would resolve the problem of scaling challenges in AI usage that have existed for a long time. As relationships simmer, it would be the start of a new institutional influx, making ADA more useful than ever to speculate on.

ETF Fever Grips the Market: Approvals on Horizon?

Cardano ETF speculation was feverish today, as time ran out with U.S. regulatory changes. The excitement is high: the filings of large issuers are looking at October rollouts, which will bring billions of new capital. A successful Bitcoin ETF might also appear as a green light, which will launch the ADA prices 50-100% overnight.

There is optimism even though the SEC is in limbo. Analysts believe the institutional interest is warming up, indicating $71m of recent upgrade capital and skyrocketing on-chain metrics. With Chainlink and others failing, the ETF narrative of Cardano is in the spotlight, with comparisons to the 2024 boom of Solana.

Price Projections Skyrocket: Two-Dollar Views, Millionaire Retirement Welcome

There is a unanimous opinion among analysts that ADA has an upward trend. The short-term projections target $0.80 in November and $2 by the end of the year, despite crashes – a sign of antifragility on the part of Cardano. The global adoption and governance upgrades give long-term visions a bolder approach: $5 by mid-2026.

Motley Fool’s bold take? Cardano can make you a millionaire when you retire. A small 10x is valuable to Ethereum at its present valuation, and it pays handsomely to HODLers. This is supported by technicals: RSI is exiting an oversold condition, MACD is crossing bullish, and volume has increased 40.

But there are still dangers – Fed rate action is on the anvil, and macro headwinds are still in place. Nonetheless, the 45 billion supply that is in circulation in Cardano provides scarcity that is unavailable in peers that are inflationary.

Lunatic Growth keeps Frenzy at the Throat

On 27 April, GitHub Cardano saw 856 commits in 73 repositories, which is an increase of 2 times the average. Hydra scaling, Ouroboros improvements, and Catalyst voting are some of the ones that prevail, and the network is set to evolve at warp speed.

Epoch 591 develops at 45% and stake pools are optimising to perform at their best. Bright future of community governance: Voices from 40+ nations influence Voltaire-era decisions, democratizing blockchain as never before.

The Road Ahead: Cardano Bull Run Only Coming

By the end of October 2025, Cardano will be even higher than it has ever been. Alonzo EVM hurls it into the territory of Ethereum, whales bet huge on big-bangs, AI integrations rethink utility, and ETF dreams haunt. ADA has underestimated its potential as far as pricing is concerned because it is sold at a very low price compared to its counterparts.

To investors, it is simple: accumulate now because the end of the triangle is near. Cardano is not only surviving but also flourishing, and it is poised to dominate the next crypto supercycle. Keep watching, things will get better in the near future; the milestone of 1 million will be achieved without delay.

1...456...1,082Page 5 of 1,082

ABC Money 2025 - 1st Edition

Magazine - 2025 Edition

Explore the latest insights, trends, and expert analyses in finance with ABC Money 2025. Stay ahead in 2025!

LEARN MORE

Leading news network for crypto, finance and business.

More from ABC

Contact

Contact: advertise@abcmoney.co.uk © ABC Money Team @ 2006

  • bitcoinBitcoin (BTC) $ 102,652.00 1.23%
  • ethereumEthereum (ETH) $ 3,347.34 4.4%
  • tetherTether (USDT) $ 1.00 0.05%
  • xrpXRP (XRP) $ 2.24 0.82%
  • bnbBNB (BNB) $ 953.40 0.57%
  • usd-coinUSDC (USDC) $ 0.999889 0.02%
  • staked-etherLido Staked Ether (STETH) $ 3,340.81 4.47%
  • tronTRON (TRX) $ 0.286645 2.19%
  • cardanoCardano (ADA) $ 0.537614 0.24%
  • avalanche-2Avalanche (AVAX) $ 16.69 1.02%
  • the-open-networkToncoin (TON) $ 1.92 2.26%
  • solanaWrapped SOL (SOL) $ 158.17 1.81%
Enable Notifications OK No thanks